Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
OGI 
OrganiGram Holdings Inc (OGI)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
07/16/2025: OGI (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
4 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $8.8
1 Year Target Price $8.8
| 3 | Strong Buy |
| 0 | Buy |
| 1 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -39.02% | Avg. Invested days 25 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance  3.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 07/16/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 191.45M USD | Price to earnings Ratio 11 | 1Y Target Price 8.8 |
Price to earnings Ratio 11 | 1Y Target Price 8.8 | ||
Volume (30-day avg) 4 | Beta 1.86 | 52 Weeks Range 0.85 - 2.08 | Updated Date 07/16/2025 |
52 Weeks Range 0.85 - 2.08 | Updated Date 07/16/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.13 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 8.7% | Operating Margin (TTM) -11.56% |
Management Effectiveness
Return on Assets (TTM) -5.56% | Return on Equity (TTM) -54.53% |
Valuation
Trailing PE 11 | Forward PE 185.19 | Enterprise Value 194282144 | Price to Sales(TTM) 0.99 |
Enterprise Value 194282144 | Price to Sales(TTM) 0.99 | ||
Enterprise Value to Revenue 1.37 | Enterprise Value to EBITDA 9.27 | Shares Outstanding 133884000 | Shares Floating 93465712 |
Shares Outstanding 133884000 | Shares Floating 93465712 | ||
Percent Insiders 32.41 | Percent Institutions 5.59 |
Upturn AI SWOT
OrganiGram Holdings Inc
Company Overview
History and Background
OrganiGram Holdings Inc. was founded in 2013 in Moncton, New Brunswick, Canada. It initially focused on producing medical cannabis and has since expanded into recreational cannabis products. It was one of the first licensed producers of cannabis in Canada.
Core Business Areas
- Cannabis Cultivation and Production: OrganiGram cultivates and produces a variety of cannabis products, including dried flower, edibles, concentrates, and vape pens.
- Product Distribution and Sales: The company distributes its products through various channels, including provincial cannabis retailers and online platforms.
- International Expansion: OrganiGram has been pursuing international expansion, primarily in Europe and Australia, through strategic partnerships and export agreements.
Leadership and Structure
The company's CEO is Beena Goldenberg. The organizational structure is based on functional departments with oversight by the executive team and a board of directors.
Top Products and Market Share
Key Offerings
- Dried Flower: OrganiGram offers a variety of dried flower strains. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
- Number of Users or Revenue: N/A
- Number of Users or Revenue: N/A
- Vape Pens: OrganiGram's vape pens are popular among consumers. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
- Edibles: OrganiGram's edibles offerings continue to grow. Market share data is highly variable and depends on specific provincial markets. Competitors include Canopy Growth, Aurora Cannabis, and Tilray. Difficult to provide marketshare data because it varies by Canadian Province which would require a table.
- Number of Users or Revenue: N/A
Market Dynamics
Industry Overview
The cannabis industry is rapidly evolving with increasing legalization and acceptance. It faces challenges like regulatory complexities and intense competition.
Positioning
OrganiGram positions itself as a producer of high-quality cannabis products with a focus on innovation and international expansion.
Total Addressable Market (TAM)
The global cannabis market is expected to reach hundreds of billions USD in the coming years. OrganiGram is positioned to capture a share of this market through its expansion and product development.
Upturn SWOT Analysis
Strengths
- Strong brand recognition in certain regions
- Innovative product development
- Strategic partnerships
- Good supply chain management
Weaknesses
- Limited market share compared to larger competitors
- Dependence on Canadian market
- Profitability challenges
- Negative press/recalls
Opportunities
- Expansion into new international markets
- Product diversification (e.g., CBD)
- Increased legalization of cannabis
- Partnerships with established brands
Threats
- Intense competition
- Regulatory changes
- Price volatility
- Supply chain disruptions
Competitors and Market Share
Key Competitors
- TLRY
- CGC
- ACB
Competitive Landscape
OrganiGram faces intense competition from larger, more established companies. It differentiates itself through innovative product development and strategic partnerships.
Growth Trajectory and Initiatives
Historical Growth: Growth has been driven by the legalization of cannabis in Canada and international expansion efforts.
Future Projections: Future growth projections depend on market conditions, regulatory developments, and the company's execution of its strategic initiatives. Analyst estimates vary.
Recent Initiatives: Recent initiatives include new product launches and expansion into international markets.
Summary
OrganiGram is a cannabis company with growth potential but faces challenges due to competition and regulatory uncertainty. The company's strengths lie in its innovative products and strategic partnerships. Profitability remains a concern, and market conditions are volatile. Continued focus on international expansion and product diversification is crucial.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Investor Relations
- Financial News Platforms
- Industry Reports
Disclaimers:
This analysis is for informational purposes only and should not be considered financial advice. Market conditions and company performance can change rapidly.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About OrganiGram Holdings Inc
Exchange NASDAQ | Headquaters Toronto, ON, Canada | ||
IPO Launch date 2014-08-27 | CEO & Director Ms. Beena G. Goldenberg | ||
Sector Healthcare | Industry Drug Manufacturers - Specialty & Generic | Full time employees 1150 | Website https://www.organigram.ca |
Full time employees 1150 | Website https://www.organigram.ca | ||
Organigram Global Inc. engages in the production and sale of cannabis and cannabis-derived products in Canada. It offers medical cannabis products, including whole flower, milled flower, pre-rolls, infused pre-rolls, vapes, beverages, gummies, and concentrates; and adult use recreational cannabis under the SHRED, Holy Mountain, Big Bag O' Buds, Monjour, Trailblazer, SHRED'ems, Edison Cannabis Co., Boxhot, Edison JOLTS, Wola, Rizzlers, DEBUNK, Tremblant, and Laurentian brands. The company also engages in the wholesale shipping of cannabis plant cuttings and dried flowers to other licensed producers. It sells cannabis products to wholesale and retail channels in the recreational and medical cannabis regimes, as well as through online. Organigram Global Inc. was formerly known as Organigram Holdings Inc. and changed its name to Organigram Global Inc. in March 2025. The company was incorporated in 2010 and is headquartered in Toronto, Canada.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.